Skip to content
10-Q

Quarterly Report

Cartesian Therapeutics, Inc. RNAC

0001453687-25-000120

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 26M sh
Shares Diluted Q3 2025 · Sep 30, 2025 26M sh
Shares Diluted Q3 2025 · Sep 30, 2025 25.96M sh
Shares Diluted Q3 2025 · Sep 30, 2024 21.47M sh
Shares Diluted Q3 2025 · Sep 30, 2024 14.56M sh
Capex Q3 2025 · Sep 30, 2025 $4.96M
Capex Q3 2025 · Sep 30, 2024 $8.39M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$56.23M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$16.67M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $143.38M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $212.61M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $219.2M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$35.84M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$2.53M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$21.79M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$6.8M
Stockholders Equity Q3 2025 · Sep 30, 2024 $752K
Stockholders Equity Q3 2025 · Jun 30, 2024 −$101.46M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$116.8M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$440.18M
Current Liabilities Q3 2025 · Sep 30, 2025 $13.8M
Current Liabilities Q3 2025 · Dec 31, 2024 $22.98M
Total Liabilities Q3 2025 · Sep 30, 2025 $408.52M
Total Liabilities Q3 2025 · Dec 31, 2024 $441.83M
Current Assets Q3 2025 · Sep 30, 2025 $147.26M
Current Assets Q3 2025 · Dec 31, 2024 $216.63M
Total Assets Q3 2025 · Sep 30, 2025 $372.68M
Total Assets Q3 2025 · Dec 31, 2024 $435.02M
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.38
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.45
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.13
Eps Diluted Q3 2025 · Sep 30, 2024 −$4.61
Eps Basic Q3 2025 · Sep 30, 2025 −$1.38
Eps Basic Q3 2025 · Sep 30, 2025 −$1.45
Eps Basic Q3 2025 · Sep 30, 2024 −$1.13
Eps Basic Q3 2025 · Sep 30, 2024 −$4.61
Sga Expense Q3 2025 · Sep 30, 2025 $7.72M
Sga Expense Q3 2025 · Sep 30, 2025 $23.27M
Sga Expense Q3 2025 · Sep 30, 2024 $6.56M
Sga Expense Q3 2025 · Sep 30, 2024 $23.04M
Rd Expense Q3 2025 · Sep 30, 2025 $13.8M
Rd Expense Q3 2025 · Sep 30, 2025 $43.35M
Rd Expense Q3 2025 · Sep 30, 2024 $11.4M
Rd Expense Q3 2025 · Sep 30, 2024 $33.8M
Net Income Q3 2025 · Sep 30, 2025 −$35.9M
Net Income Q3 2025 · Sep 30, 2025 −$37.73M
Net Income Q3 2025 · Jun 30, 2025 $15.89M
Net Income Q3 2025 · Mar 31, 2025 −$17.71M
Net Income Q3 2025 · Sep 30, 2024 −$24.18M
Net Income Q3 2025 · Sep 30, 2024 −$67.17M
Net Income Q3 2025 · Jun 30, 2024 $13.84M
Net Income Q3 2025 · Mar 31, 2024 −$56.82M
Operating Income Q3 2025 · Sep 30, 2025 −$21.07M
Operating Income Q3 2025 · Sep 30, 2025 −$64.77M
Operating Income Q3 2025 · Sep 30, 2024 −$17.58M
Operating Income Q3 2025 · Sep 30, 2024 −$17.17M
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2025 $400K
Revenue Q3 2025 · Sep 30, 2024 $0
Revenue Q3 2025 · Sep 30, 2024 $39.11M